EXOSTEM Trademark Information

Trademark by Judson Brandeis

Nutritional supplements for stem cells and exosomes - this oral herbal supplement will be taken for a month prior to getting stem cell therapy. There is a company called XOstem, but they make an IV product for type 1 diabetes and they spell their company differently. Although the pronunciation may be the same, they are vastly different things

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: EXOSTEM
Status/Status Date:
USPTO PLACED APPLICATION ON HOLD PENDING OTHER ACTION
4/9/2021
Serial Number: 90124621
Filing Date: 8/19/2020
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Nutritional supplements for stem cells and exosomes - this oral herbal supplement will be taken for a month prior to getting stem cell therapy. There is a company called XOstem, but they make an IV product for type 1 diabetes and they spell their company differently. Although the pronunciation may be the same, they are vastly different things
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: N/A
Last Applicant/Owner:
Judson Brandeis
Danville, CA 94526
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
348 Paraiso Drive
348 Paraiso Drive
Danville CA 94526
Current Status:
USPTO PLACED APPLICATION ON HOLD PENDING OTHER ACTION
4/9/2021
Correspondent Search:
JUDSON BRANDEIS is a correspondent of EXOSTEM trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on